1.Farag M, Hegazi N, Donia M. Molecular networking based LC/MS reveals novel biotransformation products of green coffee by ex vivo cultures of the human gut microbiome. Metabolomics. 2020;16(8):86. PMID: 32748036 Reference Link
1.Yan R, Zhang J, Park H-J, Park E, Oh S, Zheng H, Junn E, Voronkov M, Stock J, Mouradian M. Synergistic neuroprotection by coffee components eicosanoyl-5-hydroxytryptamide and caffeine in models of Parkinson’s disease and DLB. Proc Natl Acad Sci U S A. 2018;115(51):E12053-E12062. PMCID: PMC6304960 Reference Link
1.Asam K, Staniszewski A, Zhang H, Melideo S, Mazzeo A, Voronkov M, Huber K, Pérez E, Stock M, Stock J, Arancio O, Nicholls R. Eicosanoyl-5-hydroxytryptamide (EHT) prevents Alzheimer’s disease-related cognitive and electrophysiological impairments in mice exposed to elevated concentrations of oligomeric beta-amyloid. PLoS One. 2017;12(12):e0189413. PMCID: PMC5734769 Reference Link
1.Basurto-Islas G, Blanchard J, Tung Y, Fernández J, Voronkov M, Stock M, Zhang S, Stock J, Iqbal K. Therapeutic benefits of a component of coffee in a rat model of Alzheimer’s disease. Neurobiol Aging. 2014;35(12):2701–2712. PMCID: PMC4254318 Reference Link
